Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | -0.0032 | 0.9 |
mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.005 | 0.9 |
mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.0024 | 0.9 |
mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.0025 | 0.9 |
mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | -0.0027 | 0.9 |
mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.0025 | 0.9 |